Oncology Research and Treatment最新文献_第10页

uGI: Biomaker-Cut-Offs in der Immunonkologie uGI：免疫肿瘤学中的生物标记物临界值

IF 2.4 4区医学

Oncology Research and Treatment Pub Date : 2023-12-01 DOI: 10.1159/000535307

引用次数: 0

Large Brown Tumour of Mandible with Bleeding as Initial Presentation: A Case Report. 以出血为首发表现的下颌骨大棕色肿瘤1例。

IF 2 4区医学

Oncology Research and Treatment Pub Date : 2023-12-01 Epub Date: 2023-06-30 DOI: 10.1007/s12070-023-04003-w

Ajinkya Pawar, Priyank Rathod, Jebin Aaron, Vivek Bande, Kanika Kapur

{"title":"Large Brown Tumour of Mandible with Bleeding as Initial Presentation: A Case Report.","authors":"Ajinkya Pawar, Priyank Rathod, Jebin Aaron, Vivek Bande, Kanika Kapur","doi":"10.1007/s12070-023-04003-w","DOIUrl":"10.1007/s12070-023-04003-w","url":null,"abstract":"<p><p>Brown Tumour or Osteitis fibrous cystic or Von-Recklinghausen disease of bone is a non-malignant condition due to abnormal metabolism of bones in hyperparathyroidism. Although pathognomonic of hyperparathyroidism, brown tumours are rare and only case reports are found in literature. We report a case of brown tumour of mandible with recurrent episodes of bleeding. A 46 year old male patient presented in emergency with bleeding from ulceroproliferative mass from left floor of mouth. After control of bleeding, radiological, laboratory and histopathological investigations were done that led to the diagnosis of brown tumour of mandible in the presence of parathyroid adenoma of left lower parathyroid gland. Left upper and lower parthyroidectomy was done with segmental resection of mandible with mass and titanium plating. Brown tumour of facial bones is a rare entity. Very rarely it can reach enormous sizes to cause bleeding. Although parathyroidectomy and correction of parathormone levels cause regression of small tumours, large brown tumours with complications should be managed with surgical resection and reconstruction.</p>","PeriodicalId":19543,"journal":{"name":"Oncology Research and Treatment","volume":"25 1","pages":"3988-3992"},"PeriodicalIF":2.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86954982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie HCC - 早期检测可实现快速有效的治疗

IF 2.4 4区医学

Oncology Research and Treatment Pub Date : 2023-12-01 DOI: 10.1159/000535417

引用次数: 0

4-Jahres-Daten der CheckMate-9LA-Studie zum NSCLC CheckMate 9LA NSCLC 研究的 4 年数据

IF 2.4 4区医学

Oncology Research and Treatment Pub Date : 2023-12-01 DOI: 10.1159/000535447

引用次数: 0

Sacituzumab govitecan beim fortgeschrittenen Mammakarzinom 萨妥珠单抗戈维替康治疗晚期乳腺癌

IF 2.4 4区医学

Oncology Research and Treatment Pub Date : 2023-12-01 DOI: 10.1159/000535408